Literature DB >> 22921269

UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study.

Adriano Chiò1, Gabriele Mora, Gabriella Restagno, Maura Brunetti, Irene Ossola, Marco Barberis, Luigi Ferrucci, Antonio Canosa, Umberto Manera, Cristina Moglia, Giuseppe Fuda, Bryan J Traynor, Andrea Calvo.   

Abstract

The common variant rs12608932, located within an intron of UNC13A gene on chromosome 19p13.3, has been suggested to influence susceptibility to amyotrophic lateral sclerosis (ALS), as well as survival, in patients of north European descent. To examine this possibility further, we evaluated the association of rs12608932 with susceptibility and survival in a population-based cohort of 500 Italian ALS patients and 1457 Italian control samples. Although rs12608932 was not associated with ALS susceptibility in our series (p = 0.124), it was significantly associated with survival under the recessive model (median survival for AA/AC genotypes = 3.5 years [interquartile range, 2.2-6.4]; CC = 2.5 years [interquartile range, 1.6-4.2]; p = 0.017). Furthermore, rs12608932 genotype remained an independent prognostic factor in Cox multivariable analysis adjusting for other factors known to influence survival (p = 0.023). Overall, minor allele carrier status of rs12608932 was strongly associated with an approximate 1-year reduction of survival in ALS patients, making it a significant determinant of phenotype variation. The identification of UNC13A as a modifier of prognosis among sporadic ALS patients potentially provides a new therapeutic target aimed at slowing disease progression.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921269      PMCID: PMC3483408          DOI: 10.1016/j.neurobiolaging.2012.07.016

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  24 in total

1.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

2.  Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles.

Authors:  I Augustin; C Rosenmund; T C Südhof; N Brose
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

3.  The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model.

Authors:  Natasa Jokic; Jose-Luis Gonzalez de Aguilar; Leda Dimou; Shuo Lin; Anissa Fergani; Markus A Ruegg; Martin E Schwab; Luc Dupuis; Jean-Philippe Loeffler
Journal:  EMBO Rep       Date:  2006-10-13       Impact factor: 8.807

4.  Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.

Authors:  L Lacomblez; G Bensimon; P N Leigh; P Guillet; V Meininger
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

5.  C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population.

Authors:  Mario Sabatelli; Francesca Luisa Conforti; Marcella Zollino; Gabriele Mora; Maria Rosaria Monsurrò; Paolo Volanti; Kalliopi Marinou; Fabrizio Salvi; Massimo Corbo; Fabio Giannini; Stefania Battistini; Silvana Penco; Christian Lunetta; Aldo Quattrone; Antonio Gambardella; Giancarlo Logroscino; Isabella Simone; Ilaria Bartolomei; Fabrizio Pisano; Gioacchino Tedeschi; Amelia Conte; Rossella Spataro; Vincenzo La Bella; Claudia Caponnetto; Gianluigi Mancardi; Paola Mandich; Patrizia Sola; Jessica Mandrioli; Alan E Renton; Elisa Majounie; Yevgeniya Abramzon; Francesco Marrosu; Maria Giovanna Marrosu; Maria Rita Murru; Maria Alessandra Sotgiu; Maura Pugliatti; Carmelo Rodolico; Cristina Moglia; Andrea Calvo; Irene Ossola; Maura Brunetti; Bryan J Traynor; Giuseppe Borghero; Gabriella Restagno; Adriano Chiò
Journal:  Neurobiol Aging       Date:  2012-03-13       Impact factor: 4.673

6.  Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study.

Authors:  L Ferrucci; S Bandinelli; E Benvenuti; A Di Iorio; C Macchi; T B Harris; J M Guralnik
Journal:  J Am Geriatr Soc       Date:  2000-12       Impact factor: 5.562

7.  Epidemiology of ALS in Italy: a 10-year prospective population-based study.

Authors:  A Chiò; G Mora; A Calvo; L Mazzini; E Bottacchi; R Mutani
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

8.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; G Tsai; R W Kuncl; L Clawson; D R Cornblath; D B Drachman; A Pestronk; B L Stauch; J T Coyle
Journal:  Ann Neurol       Date:  1990-07       Impact factor: 10.422

9.  Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.

Authors:  O O'Toole; B J Traynor; P Brennan; C Sheehan; E Frost; B Corr; O Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07-18       Impact factor: 10.154

10.  A genome-wide association study identifies protein quantitative trait loci (pQTLs).

Authors:  David Melzer; John R B Perry; Dena Hernandez; Anna-Maria Corsi; Kara Stevens; Ian Rafferty; Fulvio Lauretani; Anna Murray; J Raphael Gibbs; Giuseppe Paolisso; Sajjad Rafiq; Javier Simon-Sanchez; Hana Lango; Sonja Scholz; Michael N Weedon; Sampath Arepalli; Neil Rice; Nicole Washecka; Alison Hurst; Angela Britton; William Henley; Joyce van de Leemput; Rongling Li; Anne B Newman; Greg Tranah; Tamara Harris; Vijay Panicker; Colin Dayan; Amanda Bennett; Mark I McCarthy; Aimo Ruokonen; Marjo-Riitta Jarvelin; Jack Guralnik; Stefania Bandinelli; Timothy M Frayling; Andrew Singleton; Luigi Ferrucci
Journal:  PLoS Genet       Date:  2008-05-09       Impact factor: 5.917

View more
  21 in total

Review 1.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 2.  Toward precision medicine in amyotrophic lateral sclerosis.

Authors:  Zhang-Yu Zou; Chang-Yun Liu; Chun-Hui Che; Hua-Pin Huang
Journal:  Ann Transl Med       Date:  2016-01

Review 3.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

4.  HFE p.H63D polymorphism does not influence ALS phenotype and survival.

Authors:  Adriano Chiò; Gabriele Mora; Mario Sabatelli; Claudia Caponnetto; Christian Lunetta; Bryan J Traynor; Janel O Johnson; Mike A Nalls; Andrea Calvo; Cristina Moglia; Giuseppe Borghero; Maria Rosaria Monsurrò; Vincenzo La Bella; Paolo Volanti; Isabella Simone; Fabrizio Salvi; Francesco O Logullo; Riva Nilo; Fabio Giannini; Jessica Mandrioli; Raffaella Tanel; Maria Rita Murru; Paola Mandich; Marcella Zollino; Francesca L Conforti; Silvana Penco; Maura Brunetti; Marco Barberis; Gabriella Restagno
Journal:  Neurobiol Aging       Date:  2015-06-18       Impact factor: 4.673

Review 5.  Use of biomarkers in ALS drug development and clinical trials.

Authors:  Nadine Bakkar; Ashley Boehringer; Robert Bowser
Journal:  Brain Res       Date:  2014-10-24       Impact factor: 3.252

Review 6.  Genome-wide association studies in neurology.

Authors:  Meng-Shan Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2014-12

Review 7.  Genetics of Amyotrophic Lateral Sclerosis.

Authors:  Mehdi Ghasemi; Robert H Brown
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

8.  Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study.

Authors:  Andrea Calvo; Cristina Moglia; Antonio Canosa; Stefania Cammarosano; Antonio Ilardi; Davide Bertuzzo; Bryan J Traynor; Maura Brunetti; Marco Barberis; Gabriele Mora; Federico Casale; Adriano Chiò
Journal:  Muscle Nerve       Date:  2017-04-25       Impact factor: 3.217

Review 9.  Genetic causes of amyotrophic lateral sclerosis: new genetic analysis methodologies entailing new opportunities and challenges.

Authors:  Giuseppe Marangi; Bryan J Traynor
Journal:  Brain Res       Date:  2014-10-12       Impact factor: 3.252

10.  UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: a meta-analysis.

Authors:  Baiyuan Yang; Haixia Jiang; Fang Wang; Shimei Li; Chongmin Wu; Jianjian Bao; Yongyun Zhu; Zhong Xu; Bin Liu; Hui Ren; Xinglong Yang
Journal:  Neurol Sci       Date:  2019-06-14       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.